EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE
https://doi.org/10.30895/1991-2919-2018-8-2-109-114
Abstract
The article describes theoretical foundations and successful experimental testing of a modified method of intravitreal injection (IVI) in the rabbit eye performed in the laboratory. The method needed modification because preoperative preparation described in available guidelines on IVI requires the use of medicines that are not suitable for use in vivariums in the Russian Federation. The IVI procedure for rabbits was modified by using an anesthetic regime reproducible in Russia and available eye preparations. The anesthetics used were Zoletil 50® («Virbac», France) At a dose of 1.1 mg/kg and Rometar («Bioveta, a.s.», Czech Republic) At a single intravenous dose of 5.6 mg/kg. additional analgesia was achieved by a single intramuscular injection of Ketonal® («Lek d.d.», Slovenia) At a dose of 5 mg/kg. The local anesthetic used was Inokain® eye drops («Promed Exports Pvt. Ltd.», India), the antiseptic used was Betadine® (JSC «EGIS Pharmaceutical plant», Hungary) diluted with water in the proportion of 1:10. The results of clinical examination of animals following IVI performed by lab researchers during unassisted skill training were analysed, and the results of assessment of adverse reactions associated with IVI were expressed as scores and reflected in primary records. The suggested method demonstrated good reproducibility and, therefore, may be recommended for use in preclinical studies of ophthalmic drug products in Russia.
About the Authors
A. V. KalatanovaRussian Federation
Anna V. Kalatanova - Pharmacologist of the Pharmacodynamics Group.
3/245 Zavodskaya Street, Kuzmolovsky settlement, Vsevolozhsky district, Leningrad region 188663
A. E. Katelnikova
Russian Federation
Anastasia E. Katelnikova - Head of the Immunobiological Research Group.
3/245 Zavodskaya Street, Kuzmolovsky settlement, Vsevolozhsky district, Leningrad region 188663M. N. Makarova
Russian Federation
Marina N. Makarova - Director. Doctor of Medical Sciences.
3/245 Zavodskaya Street, Kuzmolovsky settlement, Vsevolozhsky district, Leningrad region 188663
V. G. Makarov
Russian Federation
Valery G. Makarov - Deputy Director for Science, Doctor of Medical Sciences, Professor.
3/245 Zavodskaya Street, Kuzmolovsky settlement, Vsevolozhsky district, Leningrad region 188663
References
1. Boyko EV, Sosnovsky SV, Berezin RD, Kacherovich PA, Tavtilova DA. Intravitreal Injections: Theory and Practice. Ophthalmology Journal 2010;3(2):28–35 (In Russ.)
2. Shishkin MM, Yuldasheva NM, Antonyuk SV. Clinical and Morphological Aspects of the Safety of Intravitreal Injections of Various Doses of Collagenin in the Experiment. Kuban Scientific Medical Bulletin 2011;(1):194–9 (In Russ.)
3. Bely YuA, Tereshchenko AV, Yudina NN. Estimation of the Effectiveness of Intravitreal Administration of Electrolytic Sodium Hypochlorite Solution During Vitrectomy in the Treatment of Exogenous Bacterial Endophthalmitis. Ophthalmic Surgery 2007;(2):40–5 (In Russ.)
4. Panova IE, Prokopieva MYu, Avdeeva ON, Reznitskaya OV. Clinical and Instrumental Monitoring in Assessing the Effectiveness of Various Treatment Options for Neovascular Agerelated Macular Degeneration. Vestnik of the Orenburg State University 2011;(14):292–4 (In Russ.)
5. Petrova ES, Goryachev DV, Petrov MV. Modern Approaches to the Assessment of Orally Inhaled Products Bioequivalence. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2017;7(3):135–41 (In Russ.)
6. Zayit-Soudry S, Zemel E, Loewenstein A, Perlman I. Safety Evaluation of Repeated Intravitreal Injections of Bevacizumab and Ranibizumab in Rabbit Eyes. Retina 2010;30(4):671–81.
7. Sener E, Yuksel N, Yildiz DK, Yilmaz B, Ozdemir O, Caglar Y, et al. The Impact of Subconjuctivally Injected EGF and VEGF Inhibitors on Experimental Corneal Neovascularization in Rat Model. Curr Eye Res. 2011;36(11):1005–13.
8. Del Amo EM, Urtti A. Rabbit as an Animal Model for Intravitreal Pharmacokinetics: Clinical Predictability and Quality of the Published Data. Exp Eye Res. 2015;137:111–24.
9. Gilmanshin TR. Intravisitonal Administration of the Kenologist in Vitreoretinal Surgery. Cand. Med. Sci. [thesis]. Moscow; 2008 (In Russ.)
10. Yorston D. Intravitreal Injection Technique. Community Eye Health 2014;27(87):47.
11. Lai TY, Liu S, Das S, Lam DS. Intravitreal Injection-technique and Safety. Asia Pac J Ophthalmol (Phila) 2015;4(6):321–8.
12. Ioshin IE. Safety of Intravitreal Injections. Fyodorov Journal of Ophthalmic Surgery 2017;(3):71–9 (In Russ.)
13. Ahn SJ, Hohg HK, Na YM, Park SJ, Ahn J, Oh J, et al. Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs. J Vis Exp. 2016;(113). DOI: 10.3791/53878
14. Geroski DH, Edelhauser HF. Drug Delivery for Posterior Segment Eye Disease. Invest Ophthalmol Vis Sci. 2000;41(5):961–4.
15. Directive 2010/63/EU of the European Parliament and the Council of the European Union of 22 September 2010 on the Protection of Animals Used for Scientific Purposes (In Russ.)
Review
For citations:
Kalatanova A.V., Katelnikova A.E., Makarova M.N., Makarov V.G. EXPERIMENTAL TESTING OF THE MODIFIED METHOD OF INTRAVITREAL INJECTION IN THE RABBIT EYE. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2018;8(2):109-114. (In Russ.) https://doi.org/10.30895/1991-2919-2018-8-2-109-114